CN102512637B - Medicine for treating special chronic sinusitis of patients - Google Patents
Medicine for treating special chronic sinusitis of patients Download PDFInfo
- Publication number
- CN102512637B CN102512637B CN 201110451335 CN201110451335A CN102512637B CN 102512637 B CN102512637 B CN 102512637B CN 201110451335 CN201110451335 CN 201110451335 CN 201110451335 A CN201110451335 A CN 201110451335A CN 102512637 B CN102512637 B CN 102512637B
- Authority
- CN
- China
- Prior art keywords
- grams
- medicine
- gram
- chronic sinusitis
- patients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses medicine for treating special chronic sinusitis of patients. On the basis of knowledge of the traditional Chinese medicine to pathogenesis of special chronic sinusitis and the therapeutic principle of the special chronic sinusitis, the medicine refers to modern pharmacology research, and natural herbal medicine for promoting circulation, removing stasis, dispersing swelling and resuscitating is screened and plays a role according to theoretical prescription of the traditional Chinese medicine. The medicine is prepared by following ingredients including 12 grams of frankincense, 16 grams of radix astragali preparata, 12 grams of safflower carthamus, 18 grams of fructus viticis, 15 grams of herba leonuri, 10 grams of pseudo-ginseng, 15 grams of pollen typhae, 18 grams of Chinese lobelia, 20 grams of turmeric and 20 grams of prepared rehmannia root. The ingredients are mixed uniformly and crushed into fine powder with 200 meshes. A patient needs to take two pockets of the fine powder everyday, the two pockets of the fine powder are taken after being mixed with water twice.
Description
Technical field the invention belongs to technical field of Chinese medicines, relates to a kind of medicine for the treatment of special chronic sinusitis of patients, specifically the Chinese patent medicine of preparation take Chinese herbal medicine as raw material.
The background technology chronic sinusitis is one of ear nose section commonly encountered diseases, and the traditional Chinese medical science claims " nasal sinusitis ".Be to violate nasal sinuses because of heresy, damp and hotly in hole accumulate long-pendingly, refining Tianjin becomes expectorant to become mostly to be the cacorhinia of feature with turbid nasal discharge, amount due to pus.the western medical treatment acute and chronic nasal sinusitis is normal at present adopts advanced endoscopic surgery to treat, but for some inoperable special chronic sinusitis of patients (special body constitution, merge other diseases, health weak especially etc.) must expectant treatment, oral anti-inflammatory drug commonly used is helped methods such as filling in nasal cavity with metronidazole liquid and is treated this disease, these therapies are all right with interior new patient's curative effect to 1 year, but dissatisfied to the patient's curative effect that does not heal for a long time, the traditional Chinese medical science is having original advantage aspect this disease for the treatment of, the traditional Chinese medical science is thought blood circulation promoting and blood stasis dispelling, this disease of putrefaction-removing granulation-promoting therapy for treating has good effect, therefore invent a kind of medicine for the treatment of the medicine of special chronic sinusitis of patients.
Summary of the invention the purpose of this invention is to provide a kind of medicine take blood circulation promoting and blood stasis dispelling, putrefaction-removing granulation-promoting as the special chronic sinusitis for the treatment of of the rule for the treatment of, to overcome the deficiencies in the prior art.
The objective of the invention is according to pathogenetic understanding and the Therapeutic Principle thereof of motherland's medical tradition medical science to special chronic sinusitis, with reference to modern pharmacological research, the natural Chinese medicinal herb of therefrom filter out blood circulation promoting and blood stasis dispelling, subsiding a swelling and having one's ideas straightened out by the theory of Chinese medical science prescription, plays a role it.
Medicine of the present invention is made by following component:
Olibanum 12 gram Radix Astragali Preparata 16 gram Flos Carthami 12 gram Fructus Viticis 18 gram Herba Leonuri 15 gram Radix Notoginseng 10 gram Pollen Typhae 15 gram Herba Lobeliae Chinensis 18 gram Rhizoma Curcumae Longae 20 gram Radix Rehmanniae Preparata 20 grams
Above-mentioned each component mix homogeneously is ground into 200 order fine powders, is distributed into bag, every packed medicated powder 9 grams.One after each meal, is used mixing in water for oral taking at twice at two bags of every days.
Medicine of the present invention is Chinese medicine preparation, and is theoretical according to traditional Chinese medical science formula, select medicine rationally, blood circulation promoting and blood stasis dispelling, detumescence have one's ideas straightened out.Medicine of the present invention, evident in efficacy through clinical observation patient for many years, special chronic sinusitis of patients there is remarkable result.
Clinical drug of the present invention is taken result and is shown, following advantage is arranged:
It is raw material that the present invention selects natural plant, and each component meets the pharmaceutical control law regulation, utilizes the special chronic sinusitis of comprehensive function treatment of the medicine of respectively distinguishing the flavor of, nontoxic to human body without chemicals, has no side effect, safe and reliable; The present invention is powder, and effective ingredient scatters and disappears few, and curative effect is high, and is cheap, and taking convenience is without any discomfort disease; Medicine of the present invention is obvious to patient's curative effect of special chronic sinusitis, and therapeutic effect is better than other medicines.
For showing that medicine of the present invention is to the therapeutic effect of special chronic sinusitis, the present invention does the clinical observation of system through the patient of 300 routine special chronic sinusitiss, and select medical history, the state of an illness, age and special chronic sinusitis of patients 300 examples suitable with traditional therapy (the oral anti-inflammatory drug assistant is filled in nasal cavity with metronidazole liquid) to organize as a comparison, age 19-49 year, course of disease 1-20; Test group: use medicine of the present invention; Matched group: fill in the nasal cavity scheme with the oral anti-inflammatory drug assistant with metronidazole liquid merely.Observation period is 3 months years, check afterwards in a year.With reference to " disease of tcm Standardization of diagnosis and curative effect ".Recovery from illness; Subjective symptoms disappears, and the swelling of toposcopy mucosa is disappeared, and secretions disappears, and the x-ray nasal sinuses is taken the photograph sheet without extremely; Produce effects: subjective symptoms disappears, and the swelling of toposcopy mucosa is disappeared substantially, without abscess secretions, a small amount of mucus secretions is arranged sometimes, and the x-ray nasal sinuses is taken the photograph sheet and had clear improvement; Effectively: the subjective symptoms progress, toposcopy mucosa tumor disappears, and the mucus purulent secretion is arranged sometimes, and amount is front few; Invalid.Subjective symptoms and inspection are all without progressive.Clinical comparison the results are shown in Table 1.
Table 1: take medicine of the present invention with the observation of curative effect of traditional Western medicine to special chronic sinusitis.
Two groups of effective percentage of table 1 relatively
Annotate: curative effect relatively adopts statistical method, and enumeration data adopts X
2Check, two groups of effective percentage compare P＜0.01
As can be seen from Table 1, two groups of effective percentage relatively: the experimental group total effective rate is 100%, and matched group is 20%, and experimental group obviously is better than matched group (P＜0.01)
The specific embodiment:
Take raw material by following proportioning
Olibanum 12 gram Radix Astragali Preparata 16 gram Flos Carthami 12 gram Fructus Viticis 18 gram Herba Leonuri 15 gram Radix Notoginseng 10 gram Pollen Typhae 15 gram Herba Lobeliae Chinensis 18 gram Rhizoma Curcumae Longae 20 gram Radix Rehmanniae Preparata 20 grams; Above-mentioned each component mix homogeneously is ground into 200 order fine powders, is distributed into bag, every packed medicated powder 9 grams.One after each meal, is used mixing in water for oral taking at twice at two bags of every days.
Claims (1)
1. powder for the treatment of special chronic sinusitis of patients, its raw material by the following weight proportioning is made: Olibanum 12 gram Radix Astragali Preparata 16 gram Flos Carthami 12 gram Fructus Viticis 18 gram Herba Leonuri 15 gram Radix Notoginseng 10 gram Pollen Typhae 15 gram Herba Lobeliae Chinensis 18 gram Rhizoma Curcumae Longae 20 gram Radix Rehmanniae Preparata 20 grams; Above-mentioned each component mix homogeneously is ground into 200 order fine powders, is distributed into bag, every packed medicated powder 9 grams.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110451335 CN102512637B (en) | 2011-12-20 | 2011-12-20 | Medicine for treating special chronic sinusitis of patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110451335 CN102512637B (en) | 2011-12-20 | 2011-12-20 | Medicine for treating special chronic sinusitis of patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102512637A CN102512637A (en) | 2012-06-27 |
| CN102512637B true CN102512637B (en) | 2013-06-12 |
Family
ID=46283889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110451335 Expired - Fee Related CN102512637B (en) | 2011-12-20 | 2011-12-20 | Medicine for treating special chronic sinusitis of patients |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102512637B (en) |
-
2011
- 2011-12-20 CN CN 201110451335 patent/CN102512637B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102512637A (en) | 2012-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102940853B (en) | Navel paste for treating mammary gland hyperplasia diseases | |
| CN1739611A (en) | Stasis relieving oral liquid for treating rhinitis and its prepn | |
| CN101239159B (en) | Chinese medicinal composition for treating rheumatoild disease and preparation thereof | |
| CN102091296B (en) | Medicament for treating breast hyperplasia | |
| CN101804189A (en) | Drug for treating primary dysmenorrhea | |
| CN103463582A (en) | Medicinal composition for treating pelvic inflammation, as well as preparation and application thereof | |
| CN102512637B (en) | Medicine for treating special chronic sinusitis of patients | |
| CN102526613B (en) | Medicament for treating allergic cutaneous vasculitis | |
| CN102793845B (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN102091165A (en) | Traditional Chinese medicine for treating chronic hepatitis | |
| CN1265818C (en) | Leech capsule | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN101491612A (en) | Medicine for treating mammary hyperplasia and early breast cancer | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN102526622B (en) | Medicine for treating knee-joint bursitis | |
| CN1840146A (en) | Medicament for treating vitiligo | |
| CN103655875B (en) | Treatment blood sampling causes the medicine of Patients with Aplastic Anemia venous thrombosis | |
| CN103230484B (en) | Drug for treating knee osteoarthritis of patients under age of 40 | |
| CN104983954A (en) | Medicament for treating cervical hypertrophy | |
| CN102908598B (en) | Medicine for treating children fungal pneumonia | |
| CN103007032A (en) | Medicine patch for curing chronic frontal sinusitis patient | |
| CN102526610A (en) | Traditional Chinese medicine for curing multiple takayasu arteritis | |
| CN103263516B (en) | Medicine for treating cholecystitis | |
| CN102406875A (en) | Drug for treating endometriosis interna | |
| CN102048873A (en) | Traditional Chinese medicine for treating chronic hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130612 Termination date: 20131220 |